Vildagliptin and its role in the treatment of diabetes mellitus
Type 2 diabetes mellitus is a most serious medical problem throughout the world. Traditional hypoglycemic agents do not ensure long-term control ofglycemia and fail to affect the natural course of DM. An ideal hypoglycemic medicine must be efficacious, safe, and convenient to use for the preventiono...
Saved in:
| Main Author: | Yury Shavkatovich Khalimov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Endocrinology Research Centre
2010-09-01
|
| Series: | Сахарный диабет |
| Subjects: | |
| Online Access: | https://www.dia-endojournals.ru/jour/article/view/5495 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacious and safe management of type 2 diabetes mellitus using DPP-4 inhibitors
by: Alexander Sergeevich Ametov, et al.
Published: (2010-06-01) -
Clinical implementetion of vildagliptin: data from recent studies comparing incretin-based medications
by: Elena Valer'evna Biryukova
Published: (2014-03-01) -
New prospects in the treatment of diabetes mellitus
by: Minara Shamkhalovna Shamkhalova, et al.
Published: (2012-12-01) -
Galvus and Galvus Met, new registered medicinal agents for the treatment of diabetes mellitus
by: Editorial team Diabetes Mellitus
Published: (2009-06-01) -
Type 2 diabetes mellitus in elderly patients treated with endocrinologists in clinical practice
by: Elena V. Biryukova
Published: (2019-12-01)